ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Showing 21 - 27 of 27 results
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
Contributing to research that strengthens the defence of Australia
In January 2026, Mr Michael Quigley AM, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry and Innovation, and Minister for Science.
The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.
Highlights of the Energy Materials Project.
Archive of ANSTO research publications, seminars and short talks.
Highlights of the Magnetism Project.